Geoffrey Shouse, DO, PhD, discusses what motivated this retrospective review of bispecific antibodies in diffuse large B-cell lymphoma at City of Hope.
Geoffrey Shouse, DO, PhD
Advertisement
Geoffrey Shouse, DO, PhD, is an assistant professor at City of Hope Comprehensive Cancer Center in Duarte, California, and a member of the lymphoma division.
Articles by Geoffrey Shouse, DO, PhD
Geoffrey Shouse, DO, PhD, discusses the growing interest in bispecific antibodies within the field of oncology.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
Safusidenib Shows Robust, Ongoing Responses in Grade 2 IDH1-Mutant Glioma
4
Sac-TMT Demonstrates Antitumor Activity, Safety in Urothelial Carcinoma
5
